LINC01558

Across TCGA pan-cancer cohorts, LINC01558 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC01558 data layer compared with 1 for mutation status.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher LINC01558 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01558 expression acts as an unfavorable survival marker, although some lineages such as UCS and KIRC show a favorable association.

OV, LUSC, and UCS are the cancer types where LINC01558 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	II,III,IV	0.315	0.439	.001	68	view →
LUSC	DFS	Quartile	All	0.594	0.756	.005	28	view →
UCS	DFS	Tertile	IV	0.975	0.335	.024	24	view →
KIRC	OS	Tertile	All	0.920	0.845	.002	22	view →
ESCA	OS	Tertile	All	0.382	1.000	.004	18	view →
LGG	OS	Quartile	All	0.844	0.963	<.001	18	view →
BLCA	OS	Quartile	IV	0.276	0.640	.006	11	view →
BRCA	OS	Tertile	III,IV	0.655	0.450	.017	9	view →
UVM	DFS	Median	III,IV	0.212	0.670	.015	9	view →
UCEC	DFS	Quartile	IV	1.000	0.599	.015	8	view →
PCPG	DFS	Median	All	0.987	0.860	.006	8	view →
MESO	DFS	Tertile	II,III,IV	0.605	0.198	.019	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

LINC01558–OV (DFS)

Open the OV breakdown →